scispace - formally typeset
C

Catherine Stanton

Researcher at Teagasc

Publications -  592
Citations -  52749

Catherine Stanton is an academic researcher from Teagasc. The author has contributed to research in topics: Gut flora & Microbiome. The author has an hindex of 98, co-authored 540 publications receiving 40765 citations. Previous affiliations of Catherine Stanton include National University of Ireland & University College Cork.

Papers
More filters
Journal ArticleDOI

Conjugated linoleic acid concentration in M. Longissimus dorsi from heifers offered sunflower oil-based concentrates and conserved forages

Francesco Noci, +4 more
- 01 Mar 2005 - 
TL;DR: The potential for modification, and improvement from a human health perspective, of the fatty acid composition of beef muscle by dietary manipulation was confirmed and the inclusion of SFO in the diet led to an increase in the n-6:n-3 fatty acid ratio in muscle.
Journal ArticleDOI

Bifidobacterium and Lactobacillus composition at species level and gut microbiota diversity in infants before 6 weeks

Bo Yang, +11 more
- 05 Jul 2019 - 
TL;DR: In early infants with different delivery and feeding methods, gut microbiota—particularly bifidobacteria and lactobacilli communities—showed significant differences, with strong implications for physiological functions.
Journal ArticleDOI

Bile acids at the cross-roads of gut microbiome-host cardiometabolic interactions.

Paul M. Ryan, +3 more
- 28 Dec 2017 - 
TL;DR: The putative impact of microbial bile acid modification on several major phenotypes of metabolic syndrome, from obesity to heart failure is reviewed and several separate but complementary hypotheses are synthesized.
Journal ArticleDOI

Novel cultures for cheese improvement

R. Paul Ross, +4 more
- 01 Mar 2000 - 
TL;DR: Advances in the molecular genetics of food bacteria have now made possible the construction of designer cultures with the potential to improve important characteristics of cheese including production efficiency, safety and health properties, according to a report on starter and probiotic cultures.
Journal ArticleDOI

Bifidobacterium breve CCFM683 could ameliorate DSS-induced colitis in mice primarily via conjugated linoleic acid production and gut microbiota modulation

Bo Yang, +10 more
- 01 Oct 2018 - 
TL;DR: CCFM683 significantly inhibited disease activity index, colon shortening and myeloperoxidase activity, and significantly attenuated the expression of pro-inflammatory cytokines, which demonstrates that CCFM683 prevents colitis in correlation with local CLA production.